Table 1.
Procedure | Original Protocol | Base Protocol | |
---|---|---|---|
Seeding Media |
Base | MEM | Neurobasal |
Serum | 10% FBS, | - | |
10% Horse Serum | - | ||
Supplements | 1 g/L glucose, | - | |
2 mM L-glutamine | 2 mM L-glutamine | ||
1 mM sodium pyruvate | - | ||
100 μM nonessential amino acids |
- | ||
50 U/mL penicillin | 50 U/mL penicillin | ||
50 μg/mL streptomycin | 50 μg/mL streptomycin | ||
- | B27 | ||
Plate Coating |
Poly-D-Lysine | Poly-D-Lysine | |
- | 10ug/ml Fibronectin | ||
Seeding Density |
1 × 106 cells/ml in 0.5 ml/well | 1 × 106 cells/ml in 1 ml/well | |
Cell Feeding | Add 0.5 ml media at day 3 | - | |
- | Add 10 ng/ml bFGF at day 3 | ||
Treatment Day |
Day 7 | Day 10 | |
Treatment Media |
Base | MEM | Neurobasal |
Serum | 2% FBS, | 10% FBS | |
2% Horse Serum | - | ||
Supplements | 2 mM L-glutamine | 2 mM L-glutamine | |
1 mM sodium pyruvate | - | ||
50 U/mL penicillin | 50 U/mL penicillin | ||
50 μg/mL streptomycin | 50 μg/mL streptomycin | ||
- | B27 | ||
Treatment Protocol |
Change media and place microwire |
Change media and place microwire |
|
Culture stop day |
Day 17 (10 days after treat) | Day 17 (7 days after treat) | |
Frequency of scar formation |
<30% | ~100% | |
Typical Scar Index |
0–2 | 7–8 |